Who have Low birth weight baby with Levetiracetam - from FDA reports

Low birth weight baby is found among people who take Levetiracetam, especially for people who are 0-1 old , have been taking the drug for 6 - 12 months, also take medication Clobazam, and have Foetal exposure during pregnancy. This study is created by eHealthMe based on reports of 27,557 people who have side effects when taking Levetiracetam from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.

On Jan, 10, 2019

27,557 people reported to have side effects when taking Levetiracetam.
Among them, 67 people (0.24%) have Low birth weight baby

Number of reports submitted per year:

Could Levetiracetam cause Low birth weight baby?

Time on Levetiracetam when people have Low birth weight baby *:

  • < 1 month: 25 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 75 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Age of people who have Low birth weight baby when taking Levetiracetam *:

  • 0-1: 100 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  1. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 7 people, 10.45%
  2. Sedation: 3 people, 4.48%
  3. The Flu (the flu is caused by an influenza virus): 2 people, 2.99%
  4. Neuroleptic Malignant Syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents): 2 people, 2.99%
  5. Takayasu's Arteritis (an inflammation of the aorta -- the artery that carries blood from the heart to the rest of the body): 1 person, 1.49%
  6. Psychomotor Hyperactivity (feelings of extreme restlessness): 1 person, 1.49%
  7. Maternal Therapy To Enhance Foetal Lung Maturity: 1 person, 1.49%
  8. Hypotonia (low muscle tone): 1 person, 1.49%
  9. Developmental Delay: 1 person, 1.49%

Top co-used drugs for these people *:

  1. Clobazam: 5 people, 7.46%
  2. Vigabatrin: 1 person, 1.49%
  3. Topiramate: 1 person, 1.49%
  4. Primidone: 1 person, 1.49%
  5. Pregabalin: 1 person, 1.49%
  6. Phenytoin: 1 person, 1.49%
  7. Oxcarbazepine: 1 person, 1.49%
  8. Lamotrigine: 1 person, 1.49%
  9. Lacosamide: 1 person, 1.49%
  10. Gabapentin: 1 person, 1.49%

Top other side effects for these people *:

  1. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 62 people, 92.54%
  2. Premature Baby: 33 people, 49.25%
  3. Congenital Anomaly (birth defect): 9 people, 13.43%
  4. Neonatal Respiratory Depression (the rate and/or depth of respiration are insufficient to maintain adequate gas exchange in the lungs in neonate): 4 people, 5.97%
  5. Rhesus Incompatibility (a condition that occurs during pregnancy if a woman has rh-negative blood and her baby has rh-positive blood): 4 people, 5.97%
  6. Foetal Growth Restriction (poor growth of a baby while in the mother's womb during pregnancy): 4 people, 5.97%
  7. Maternal Exposure During Pregnancy (use of substance during pregnancy): 4 people, 5.97%
  8. Paroxysmal Supraventricular Tachycardia: 4 people, 5.97%
  9. Drug Withdrawal Syndrome Neonatal (prenatal nas is caused by discontinuation of drugs taken by the pregnant mother): 4 people, 5.97%
  10. Foetal Distress Syndrome (altered heart rate or rhythm and leading tocompromised blood flow or changes in blood chemistry of foetus): 3 people, 4.48%

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study

Do you have Low birth weight baby while taking Levetiracetam?

You are not alone:

Related studies


Levetiracetam has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from Levetiracetam 27,967 users)

Low birth weight baby

Low birth weight baby has been reported by people with foetal exposure during pregnancy, drug dependence, epilepsy, high blood pressure, depression (latest reports from 3,524 Low birth weight baby patients).

Drugs that are associated with Low birth weight baby
Low birth weight baby (415 drugs)
Could your condition cause Low birth weight baby
Low birth weight baby (299 conditions)
Levetiracetam side effects

Browse by age

0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levetiracetam
a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

What would happen?

Predict new side effects and undetected conditions when you take Levetiracetam and have Low birth weight baby

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...


Thank you!